Overview
Fukuda-Miyanomae-Nakata syndrome is an extremely rare genetic condition that has been described in only a handful of patients in the medical literature. This syndrome is also sometimes referred to by its Orphanet designation (ORPHA:2060). It is characterized by a combination of skeletal abnormalities, intellectual disability, and distinctive facial features. Affected individuals may show short stature, abnormalities of the bones (particularly the spine and limbs), and delays in reaching developmental milestones such as walking and talking. Because so few cases have been reported, our understanding of this condition remains limited. The exact genetic cause has not been firmly established, and there is no specific cure or targeted treatment available. Management focuses on addressing individual symptoms — for example, orthopedic care for bone problems, special education support for learning difficulties, and physical or occupational therapy to help with motor skills. Patients benefit from a coordinated team of specialists who can monitor growth, development, and any complications that may arise over time. If you or your child has been diagnosed with this condition, working closely with a clinical geneticist is an important first step to guide care and connect with available resources.
Key symptoms:
Short statureSkeletal abnormalitiesIntellectual disability or learning difficultiesDelayed development of motor skillsUnusual facial featuresAbnormalities of the spineLimb bone abnormalitiesSpeech delay
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Fukuda-Miyanomae-Nakata syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Fukuda-Miyanomae-Nakata syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Fukuda-Miyanomae-Nakata syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Fukuda-Miyanomae-Nakata syndrome.
Community
No community posts yet. Be the first to share your experience with Fukuda-Miyanomae-Nakata syndrome.
Start the conversation →Latest news about Fukuda-Miyanomae-Nakata syndrome
No recent news articles for Fukuda-Miyanomae-Nakata syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific tests can help confirm this diagnosis?,Should we pursue whole exome or whole genome sequencing to look for a genetic cause?,What therapies do you recommend to support my child's development?,How often should we schedule follow-up visits and imaging for skeletal monitoring?,Are there any clinical studies or research programs we could participate in?,What educational supports should we request from the school?,Is genetic counseling recommended for our family regarding future pregnancies?
Common questions about Fukuda-Miyanomae-Nakata syndrome
What is Fukuda-Miyanomae-Nakata syndrome?
Fukuda-Miyanomae-Nakata syndrome is an extremely rare genetic condition that has been described in only a handful of patients in the medical literature. This syndrome is also sometimes referred to by its Orphanet designation (ORPHA:2060). It is characterized by a combination of skeletal abnormalities, intellectual disability, and distinctive facial features. Affected individuals may show short stature, abnormalities of the bones (particularly the spine and limbs), and delays in reaching developmental milestones such as walking and talking. Because so few cases have been reported, our understa
At what age does Fukuda-Miyanomae-Nakata syndrome typically begin?
Typical onset of Fukuda-Miyanomae-Nakata syndrome is childhood. Age of onset can vary across affected individuals.